80 Biggest Movers From Yesterday

80 最大的推動者從昨天

Benzinga Real-time News · 2020/08/25 17:34

Gainers

Cancer Genetics, Inc. (NASDAQ:CGIX) shares climbed 114.8% to close at $6.25 on Monday after the company signed a definitive merger agreement with StemoniX.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares climbed 48.3% to close at $3.90 after the U.S. FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Tortoise Acquisition Corp. (NASDAQ:SHLL) gained 33.7% to close at $40.00. After its first successful specialty purpose acquisition company, Tortoise Acquisition Corp. is launching a second SPAC. Tortoise Acquisition Corp. will offer 250 million shares at a price of $10 per share, according to a Monday SEC filing.
iBio, Inc. (NASDAQ:IBIO) surged 30% to close at $2.21 after falling over 14% on Friday.
TravelCenters of America Inc. (NASDAQ:TA) shares surged 29.6% to close at $22.37. BTIG initiated coverage on TravelCenters Of America with a Buy rating and a price target of $34.
VivoPower International PLC (NASDAQ:VVPR) shares climbed 25.6% to close at $3.29 after the company reported better-than-expected preliminary results for FY20.
AutoWeb, Inc. (NASDAQ:AUTO) gained 24.1% to close at $3.45. AutoWeb, last week, said it sees preliminary July sales at $6.1 million.
Nano-X Imaging Ltd. (NASDAQ:NNOX) shares jumped 23% to close at $26.70. Nano-X Imaging shares gained 21% on Friday after pricing its IPO at $18 per share.
Blink Charging Co. (NASDAQ:BLNK) gained 18.7% to close at $8.07 in sympathy with the overall market.
Orchard Therapeutics plc (NASDAQ:ORTX) rose 18.7% to close at $5.53. Orchard Therapeutics announced clinical data presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation.
Velocity Financial, Inc. (NYSE:VEL) gained 18.6% to close at $6.25. Velocity Financial, earlier during the month, released Q2 results.
XpresSpa Group, Inc. (NASDAQ:XSPA) climbed 18.4% to close at $3.22 as the company announced it had cut the waiting time for COVID-19 tests conducted at airports from 48 hours to under 15 minutes.
Nabors Industries Ltd. (NYSE:NBR) shares surged 17.8% to close at $39.34.
Transocean Ltd. (NYSE:RIG) climbed 17.5% to close at $1.34. Transocean shares dipped over 28% on Friday on bankruptcy concerns.
Kamada Ltd. (NASDAQ:KMDA) gained 17.3% to close at $11.73 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Party City Holdco Inc. (NASDAQ:PRTY) surged 16.5% to close at $2.33 after declining 11% on Friday.
Groupon, Inc. (NASDAQ:GRPN) gained 16.2% to close at $ 32.58 in sympathy with the overall market.
RumbleON, Inc. (NASDAQ:RMBL) jumped 16.1% to close at $32.98. A Form 4 filing filed with the SEC on Monday, August 24 showed that and Chesrown Marshall bought 1,500 shares at an average price of $28.52.
Bristow Group Inc. (NASDAQ:VTOL) shares gained 15.3% to close at $ 24.39.
Travelzoo (NASDAQ:TZOO) surged 15.3% to close at $7.48.
GTT Communications, Inc. (NYSE:GTT) shares rose 14.4% to close at $4.92. GTT, last week, received NYSE notice regarding delayed form 10-Q filing.
Meredith Corporation (NYSE:MDP) gained 14.4% to close at $ 14.25.
ADMA Biologics, Inc. (NASDAQ:ADMA) shares rose 13.9% to close at $2.87 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Li Auto Inc. (NASDAQ:LI) gained 13.8% to close at $17.09.
Brainsway Ltd. (NASDAQ:BWAY) rose 13.4% to close at $7.35 after the company received 501(k) clearance from the FDA for its deep transcranial magnetic stimulation system as an aid in short-term smoking cessation.
Synchronoss Technologies, Inc. (NASDAQ:SNCR) gained 13.4% to close at $4.39. Synchronoss Technologies reported better-than-expected Q2 results earlier in the month.
Rocket Companies, Inc. (NYSE:RKT) climbed 12.4% to close at $29.11 after surging around 9% on Friday. Rocket Companies is expected to report Q2 results on September 2.
LG Display Co., Ltd. (NYSE:LPL) rose 12.3% to close at $6.28.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 11.1% to close at $4.11 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Abraxas Petroleum Corporation (NASDAQ:AXAS) gained 10.8% to close at $0.1956 after Angelo, Gordon & Co. reported a 16.6% active stake in the company.
Kelly Services, Inc. (NASDAQ:KELYB) shares gained 10.6% to close at $35.17 after gaining 26% on Friday.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) shares gained 8.6% to close at $8.20 after surging over 12% on Friday. Catabasis Pharmaceuticals posted a Q2 loss earlier during the month.
Velocity Financial, Inc. (NYSE:VEL) shares rose 8.6% to close at $6.25 after jumping 25% on Friday.
Liminal BioSciences Inc. (NASDAQ:LMNL) gained 7.1% to close at $13.59 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
T2 Biosystems, Inc. (NASDAQ:TTOO) gained 6.9% to close at $1.55 after declining around 6% on Friday. T2 Biosystems, earlier during the month, reported upbeat quarterly results.
XBiotech Inc (NASDAQ:XBIT) gained 6.6% to close at $19.57 after the company said the FDA issued an emergency use authorization for COVID-19 Convalescent Plasma as a treatment for COVID-19, which opens the door for its antibody screening technology used to identify CCP.
Oblong Inc. (NASDAQ:OBLG) gained 5.4% to close at $2.34 after the company said it secured largest initial mezzanine order in its history.
Proteostasis Therapeutics Inc (NYSE:PTI) gained 4.6% to close at $1.36 after the company and Yumanity Therapeutics reported a merger agreement.

Check out these big penny stock gainers and losers

Losers

Odonate Therapeutics Inc (NASDAQ:ODT) shares dipped 45.4% to close at $18.33 on Monday after the company announced the results from CONTESSA, a phase 3 study of Tesetaxel.
Northern Dynasty Minerals Ltd. (NYSE:NAK) dropped 38.2% to close at $0.8960 in pre-market trading following a WSJ report suggesting the company's gold and copper mine planned for Alaska faces a roadblock by the Trump administration over environmental concerns.
FTS International, Inc. (NYSE:FTSI) shares fell 36.5% to close at $3.15. FTS International reported an agreement with majority of its secured debtholders on restructuring support agreement to convert over $400 million of debt to equity.
Hexindai Inc. (NASDAQ:HX) shares declined 26.4% to close at $1.90.
Tricida, Inc. (NASDAQ:TCDA) shares fell 23.6% to close at $10.11 after the company received a Complete Response Letter from the FDA for its New Drug Application for Veverimer.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) shares dropped 21.8% to close at $3.74. Trevi Therapeutics released Q2 results earlier during the month.
MOGU Inc. (NYSE:MOGU) fell 20.4% to close at $2.50 after the company reported Q1 results.
CHF Solutions, Inc. (NASDAQ:CHFS) dipped 20% to close at $0.3680 after dropping 7% on Friday. CHF Solutions, last week, reported the pricing of $12.5 million offering at $0.45 per unit.
NanoViricides, Inc. (NYSE:NNVC) dipped 19.2% to close at $3.92.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares fell 19.1% to close at $8.12. Sorrento Therapeutics, last week, announced it has entered into a merger agreement to acquire SmartPharm and develop a pipeline of gene-encoded therapeutic antibodies, starting with neutralizing antibodies to treat Covid-19 and cancer therapeutics.
Vir Biotechnology, Inc. (NASDAQ:VIR) dropped 18.8% to close at $42.95. Vir Biotechnology and Harbour BioMed announced plans to collaborate on development and commercialization of novel therapeutic molecules in the field of immuno-oncology and infectious disease.
Lifeway Foods, Inc. (NASDAQ:LWAY) dipped 17.7% to close at $4.79.
GrowGeneration Corp. (NASDAQ:GRWG) fell 17.3% to close at $14.34. On Friday, Hindenburg published a bearish piece on GrowGeneration.
Urban One, Inc. (NASDAQ:UONE) dropped 17.3% to close at $4.15. Urban One, earlier during the month, reported a $25 million at-the-market equity offering program.
Immunic, Inc. (NASDAQ:IMUX) dipped 17.1% to close at $15.29.
Ovid Therapeutics Inc. (NASDAQ:OVID) fell 16.8% to close at $6.37. Ovid Therapeutics released Q2 results earlier in the month.
Kirkland's, Inc. (NASDAQ:KIRK) fell 16.6% to close at $10.18. Kirkland's is expected to release Q2 earnings on September 3.
Akers Biosciences, Inc. (NASDAQ:AKER) dipped 16.6% to close at $4.38 after falling 11% on Friday. Akers Biosciences, earlier during the month, announced a 1.207 million share common stock offering at $5.67 per share.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares fell 16.3% to close at $1.95.
Vuzix Corporation (NASDAQ:VUZI) fell 15.8% to close at $3.63. Vuzix shares climbed over 17% on Friday after Rozetta selected the company's Smart Glasses for two separate translation-centric solutions.
Co-Diagnostics, Inc. (NASDAQ:CODX) declined 15.4% to close at $12.57. Co-Diagnostics, earlier during the month, reported worse-than-expected Q2 results.
Marathon Patent Group, Inc. (NASDAQ:MARA) fell 14.8% to close at $2.31. Marathon Patent Group, earlier in the month, announced it has entered into a long term purchase contract with Bitmain for the purchase of 10,500 next-generation Antminer S-19 Pro ASIC Miners.
Westwater Resources, Inc. (NASDAQ:WWR) shares dipped 14.4% to close at $1.84. Westwater Resources posted a Q2 loss of $0.43 per share earlier in the month.
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) fell 14.2% to close at $0.3950. Hancock Jaffe Laboratories shares climbed 64% on Friday after the company announced two additional VenoValve patients from its first-in-man clinical study in Columbia reached the one-year milestone following VenoValve surgery and chronic venous insufficiency significantly improved in both patients.
Yield10 Bioscience Inc (NASDAQ:YTEN) shares fell 14.1% to close at $4.34 after the company announced a common stock offering of 835,000 shares at $4.25 per share.
Calyxt, Inc. (NASDAQ:CLXT) dropped 13.4% to close at $4.98 after declining 13% on Friday.
Novavax, Inc (NASDAQ:NVAX) fell 13.3% to close at $119.26 after reports suggesting Trump is considering fast-tracking AstraZeneca's coronavirus vaccine candidate, adding to competitive pressures. Meanwhile, Novavax initiated Phase 2 portion of Phase 1/2 clinical trial of coronavirus vaccine.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) dropped 13.2% to close at $12.24 following a report that AstraZeneca’s COVID-19 vaccine maybe fast-tracked for approval in the United States.
VBI Vaccines Inc. (NASDAQ:VBIV) shares fell 12.7% to close at $3.1850 after dropping over 6% on Friday. VBI Vaccines, last week, signed a manufacturing deal with Therapure Biomanufacturing for coronavirus vaccine candidates.
Jaguar Health, Inc. (NASDAQ:JAGX) fell 12.1% to close at $0.3930 after declining over 10% on Friday. Jaguar Health, last week, issued updates on investigator-initiated trials of crofelemer.
AIM ImmunoTech Inc (NYSE:AIM) fell 11.7% to close at $2.12. On Friday, CEO Equels Thomas K. filed a Form 4 with the SEC. The insider bought 10,730 shares at an average price of $2.33.
Capitala Finance Corp. (NASDAQ:CPTA) shares fell 11.5% to close at $10.99.
Atossa Therapeutics, Inc. (NASDAQ:ATOS) shares fell 10.7% to close at $3.02. Atossa Therapeutics, last week announced that it has enrolled and dosed the first cohort of healthy participants in the Phase 1 clinical study using AT-301, being administered by nasal spray.
Vaxart, Inc. (NASDAQ:VXRT) fell 10.5% to close at $7.36.
SPAR Group, Inc. (NASDAQ:SGRP) shares fell 10.4% to close at $0.9320 after jumping 20% on Friday. SPAR Group, last week, named Fay DeVriese as new Chief Financial Officer.
DarioHealth Corp. (NASDAQ:DRIO) shares tumbled 10.1% to close at $16.73.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) dropped 9.7% to close at $0.6097. EyePoint Pharmaceuticals secured a new purchase and marketing agreement with Vantage Outsourcing for DEXYCU.
Mohawk Group Holdings, Inc. (NYSE:MWK) fell 9.5% to close at $7.95 after the company reported a common stock offering of approximately 3.36 million shares at $7 per share.
Midatech Pharma plc (NASDAQ:MTP) fell 7.8% to close at $2.36 after surging 22% on Friday.
NN, Inc. (NASDAQ:NNBR) fell 7.7% to close at $5.48 after the company reported the sale of life sciences division for $825 million.
Naked Brand Group Limited (NASDAQ:NAKD) fell 7% to close at $0.2851 after declining 11% on Friday. Naked Brand Group, last week, entered into a global amendment with St.George Investments amending convertible promissory note issued by the company.
Super League Gaming, Inc. (NASDAQ:SLGG) fell 4.9% to close at $2.14. Super League, on Friday, announced an exclusive recreational esports partnership for its upcoming new game Venture Valley.

Gainers

贏家

Cancer Genetics, Inc. (NASDAQ:CGIX) shares climbed 114.8% to close at $6.25 on Monday after the company signed a definitive merger agreement with StemoniX.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares climbed 48.3% to close at $3.90 after the U.S. FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Tortoise Acquisition Corp. (NASDAQ:SHLL) gained 33.7% to close at $40.00. After its first successful specialty purpose acquisition company, Tortoise Acquisition Corp. is launching a second SPAC. Tortoise Acquisition Corp. will offer 250 million shares at a price of $10 per share, according to a Monday SEC filing.
iBio, Inc. (NASDAQ:IBIO) surged 30% to close at $2.21 after falling over 14% on Friday.
TravelCenters of America Inc. (NASDAQ:TA) shares surged 29.6% to close at $22.37. BTIG initiated coverage on TravelCenters Of America with a Buy rating and a price target of $34.
VivoPower International PLC (NASDAQ:VVPR) shares climbed 25.6% to close at $3.29 after the company reported better-than-expected preliminary results for FY20.
AutoWeb, Inc. (NASDAQ:AUTO) gained 24.1% to close at $3.45. AutoWeb, last week, said it sees preliminary July sales at $6.1 million.
Nano-X Imaging Ltd. (NASDAQ:NNOX) shares jumped 23% to close at $26.70. Nano-X Imaging shares gained 21% on Friday after pricing its IPO at $18 per share.
Blink Charging Co. (NASDAQ:BLNK) gained 18.7% to close at $8.07 in sympathy with the overall market.
Orchard Therapeutics plc (NASDAQ:ORTX) rose 18.7% to close at $5.53. Orchard Therapeutics announced clinical data presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation.
Velocity Financial, Inc. (NYSE:VEL) gained 18.6% to close at $6.25. Velocity Financial, earlier during the month, released Q2 results.
XpresSpa Group, Inc. (NASDAQ:XSPA) climbed 18.4% to close at $3.22 as the company announced it had cut the waiting time for COVID-19 tests conducted at airports from 48 hours to under 15 minutes.
Nabors Industries Ltd. (NYSE:NBR) shares surged 17.8% to close at $39.34.
Transocean Ltd. (NYSE:RIG) climbed 17.5% to close at $1.34. Transocean shares dipped over 28% on Friday on bankruptcy concerns.
Kamada Ltd. (NASDAQ:KMDA) gained 17.3% to close at $11.73 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Party City Holdco Inc. (NASDAQ:PRTY) surged 16.5% to close at $2.33 after declining 11% on Friday.
Groupon, Inc. (NASDAQ:GRPN) gained 16.2% to close at $ 32.58 in sympathy with the overall market.
RumbleON, Inc. (NASDAQ:RMBL) jumped 16.1% to close at $32.98. A Form 4 filing filed with the SEC on Monday, August 24 showed that and Chesrown Marshall bought 1,500 shares at an average price of $28.52.
Bristow Group Inc. (NASDAQ:VTOL) shares gained 15.3% to close at $ 24.39.
Travelzoo (NASDAQ:TZOO) surged 15.3% to close at $7.48.
GTT Communications, Inc. (NYSE:GTT) shares rose 14.4% to close at $4.92. GTT, last week, received NYSE notice regarding delayed form 10-Q filing.
Meredith Corporation (NYSE:MDP) gained 14.4% to close at $ 14.25.
ADMA Biologics, Inc. (NASDAQ:ADMA) shares rose 13.9% to close at $2.87 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Li Auto Inc. (NASDAQ:LI) gained 13.8% to close at $17.09.
Brainsway Ltd. (NASDAQ:BWAY) rose 13.4% to close at $7.35 after the company received 501(k) clearance from the FDA for its deep transcranial magnetic stimulation system as an aid in short-term smoking cessation.
Synchronoss Technologies, Inc. (NASDAQ:SNCR) gained 13.4% to close at $4.39. Synchronoss Technologies reported better-than-expected Q2 results earlier in the month.
Rocket Companies, Inc. (NYSE:RKT) climbed 12.4% to close at $29.11 after surging around 9% on Friday. Rocket Companies is expected to report Q2 results on September 2.
LG Display Co., Ltd. (NYSE:LPL) rose 12.3% to close at $6.28.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 11.1% to close at $4.11 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
Abraxas Petroleum Corporation (NASDAQ:AXAS) gained 10.8% to close at $0.1956 after Angelo, Gordon & Co. reported a 16.6% active stake in the company.
Kelly Services, Inc. (NASDAQ:KELYB) shares gained 10.6% to close at $35.17 after gaining 26% on Friday.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) shares gained 8.6% to close at $8.20 after surging over 12% on Friday. Catabasis Pharmaceuticals posted a Q2 loss earlier during the month.
Velocity Financial, Inc. (NYSE:VEL) shares rose 8.6% to close at $6.25 after jumping 25% on Friday.
Liminal BioSciences Inc. (NASDAQ:LMNL) gained 7.1% to close at $13.59 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
T2 Biosystems, Inc. (NASDAQ:TTOO) gained 6.9% to close at $1.55 after declining around 6% on Friday. T2 Biosystems, earlier during the month, reported upbeat quarterly results.
XBiotech Inc (NASDAQ:XBIT) gained 6.6% to close at $19.57 after the company said the FDA issued an emergency use authorization for COVID-19 Convalescent Plasma as a treatment for COVID-19, which opens the door for its antibody screening technology used to identify CCP.
Oblong Inc. (NASDAQ:OBLG) gained 5.4% to close at $2.34 after the company said it secured largest initial mezzanine order in its history.
Proteostasis Therapeutics Inc (NYSE:PTI) gained 4.6% to close at $1.36 after the company and Yumanity Therapeutics reported a merger agreement.

癌症基因公司。(納斯達克：CGIX週一，在該公司與StemoniX簽署最終合併協議後，該公司股價上漲114.8，收於6.25美元。
十四行詩生物治療控股公司(納斯達克：宋氏)股價攀升48.3%，收於3.90美元，此前美國食品和藥物管理局發佈緊急使用授權，允許住院患者研究恢復期血漿治療新冠肺炎。
烏龜收購公司(納斯達克：SHLL)上漲33.7%，收於40.00美元。繼第一家成功的特殊用途收購公司之後，烏龜收購公司正在推出第二家SPAC。據美國證券交易委員會週一提交的文件顯示，海龜股份有限公司將發行2.5億股股票，發行價為每股10美元。
IBio，Inc.(納斯達克：IBio)飆升30%，收於2.21美元，上週五下跌超過14%。
美國旅遊中心公司。(納斯達克：標記)股價飆升29.6%，收於22.37美元。BTIG對美國旅遊中心的報道評級為買入，目標價為34美元。
VivoPower International PLC(納斯達克：VVPR)股價攀升25.6%，收報3.29美元，此前該公司公佈了好於預期的20財年初步業績。
AutoWeb，Inc.(納斯達克：自動)上漲24.1%，收於3.45美元。AutoWeb上週表示，預計7月份的初步銷售額為610萬美元。
Nano-X成像有限公司(納斯達克：氮氧化物)股價跳漲23%，收於26.70美元。在將IPO定價為每股18美元后，Nano-X Image的股價週五上漲了21%。
閃電充電公司(納斯達克：BLNK)上漲18.7%，收於8.07美元，與大盤一致。
果園治療公司(納斯達克：ORTX)上揚18.7%，收報5.53美元。Orchard Treeutics在第46屆歐洲血液和骨髓移植學會年會上宣佈了臨牀數據展示。
Velity金融公司(紐約證券交易所：韋爾)上漲18.6%，收於6.25美元。Velity Financial在本月早些時候發佈了第二季度業績。
XpresSpa集團公司(納斯達克：XSPA)攀升18.4%，收於3.22美元，該公司宣佈已將機場新冠肺炎檢測的等待時間從48小時縮短至15分鐘以下。
納博斯實業有限公司(紐約證券交易所：丁腈橡膠)股價飆升17.8%，收於39.34美元。
越洋公司(紐約證券交易所：鑽機)攀升17.5%，收報1.34美元。由於對破產的擔憂，越洋公司的股價週五下跌了28%以上。
卡瑪達有限公司(納斯達克：KMDA)上漲17.3%，收於11.73美元，此前美國食品和藥物管理局發佈緊急使用授權，研究療養血漿用於治療住院患者的新冠肺炎。
Party City Holdco Inc.(納斯達克：PRTY)飆升16.5%，收於2.33美元，上週五下跌11%。
Groupon公司(納斯達克：GRPN)上漲16.2%，收於32.58美元，與大盤一致。
RumbleON，Inc.(納斯達克：人民幣)跳漲16.1%，收報32.98美元。8月24日星期一提交給美國證券交易委員會的Form 4文件顯示，切斯布朗·馬歇爾以28.52美元的平均價格購買了1,500股票。
布里斯托集團。(納斯達克：垂直起降)股價上漲15.3%，收於24.39美元。
旅遊動物園(納斯達克：TZOO)急升15.3%，收報7.48美元。
GTT通信公司(紐約證券交易所：GTT)股價上漲14.4%，收於4.92美元。GTT上週收到了紐約證券交易所關於10-Q表格提交延遲的通知。
梅雷迪思公司(紐約證券交易所：MDP)上漲14.4%，收於14.25美元。
ADMA生物製品公司(納斯達克：ADMA)股價上漲13.9%，收於2.87美元，此前美國食品和藥物管理局發佈緊急使用授權，允許住院患者使用研究恢復期血漿治療新冠肺炎。
理想汽車股份有限公司(納斯達克：李)上漲13.8%，收於17.09美元。
Brainsway Ltd.(納斯達克：BWAY)上漲13.4%，收於7.35美元，此前該公司獲得了FDA的501(K)批准，其深度經顱磁刺激系統有助於短期戒煙。
Synchronoss技術公司(納斯達克：SNCR)上漲13.4%，收於4.39美元。本月早些時候，Synchronoss Technologies公佈了好於預期的第二季度業績。
火箭公司。(紐約證券交易所：RKT)攀升12.4%，收報29.11美元，上週五曾飆升約9%。火箭公司預計將於9月2日公佈第二季度業績。
LG Display Co.(紐約證券交易所：LPL)上漲12.3%，收報6.28美元。
產熱控股公司(納斯達克：THMO)上漲11.1%，收於4.11美元，此前美國食品和藥物管理局發佈緊急使用授權，允許住院患者使用研究恢復期血漿治療新冠肺炎。
阿布拉克薩斯石油公司(納斯達克：AXAS)股價上漲10.8%，收於0.1956美元，此前Angelo，Gordon&Co.公佈持有該公司16.6%的活躍股份。
凱利服務公司(納斯達克：凱萊布)股價上漲10.6%，收於35.17美元，上週五上漲26%。
卡塔巴西製藥公司(納斯達克：CATB)股價上漲8.6%，收於8.20美元，上週五飆升逾12%。本月早些時候，Catabsis製藥公司公佈了第二季度虧損。
Velity金融公司(紐約證券交易所：韋爾)股價上漲8.6%，收於6.25美元，上週五躍升25%。
利米納生物科學公司。(納斯達克：LMNL)上漲7.1%，收於13.59美元，此前美國食品和藥物管理局發佈緊急使用授權，允許住院患者研究恢復期血漿治療新冠肺炎。
T2生物系統公司(納斯達克：TTOO)上漲6.9%，收於1.55美元，上週五下跌約6%。T2生物系統公司本月早些時候公佈了樂觀的季度業績。
XBiotech Inc.(納斯達克：XBIT)上漲6.6%，收於19.57美元，此前該公司表示，美國食品和藥物管理局發佈了新冠肺炎療養血漿的緊急使用授權，用於治療新冠肺炎，這為其用於識別CCP身份的抗體篩查技術打開了大門。
Obrong Inc.(納斯達克：OBLG)上漲5.4%，收於2.34美元，此前該公司表示，獲得了其歷史上最大的夾層訂單。
蛋白抑制治療公司(紐約證券交易所：PTI)上漲4.6%，收於1.36美元，此前該公司和Yumanity治療公司公佈了合併協議。

Check out these big penny stock gainers and losers

看看這些微不足道的股票漲跌股

Losers

失敗者

Odonate Therapeutics Inc (NASDAQ:ODT) shares dipped 45.4% to close at $18.33 on Monday after the company announced the results from CONTESSA, a phase 3 study of Tesetaxel.
Northern Dynasty Minerals Ltd. (NYSE:NAK) dropped 38.2% to close at $0.8960 in pre-market trading following a WSJ report suggesting the company's gold and copper mine planned for Alaska faces a roadblock by the Trump administration over environmental concerns.
FTS International, Inc. (NYSE:FTSI) shares fell 36.5% to close at $3.15. FTS International reported an agreement with majority of its secured debtholders on restructuring support agreement to convert over $400 million of debt to equity.
Hexindai Inc. (NASDAQ:HX) shares declined 26.4% to close at $1.90.
Tricida, Inc. (NASDAQ:TCDA) shares fell 23.6% to close at $10.11 after the company received a Complete Response Letter from the FDA for its New Drug Application for Veverimer.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) shares dropped 21.8% to close at $3.74. Trevi Therapeutics released Q2 results earlier during the month.
MOGU Inc. (NYSE:MOGU) fell 20.4% to close at $2.50 after the company reported Q1 results.
CHF Solutions, Inc. (NASDAQ:CHFS) dipped 20% to close at $0.3680 after dropping 7% on Friday. CHF Solutions, last week, reported the pricing of $12.5 million offering at $0.45 per unit.
NanoViricides, Inc. (NYSE:NNVC) dipped 19.2% to close at $3.92.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares fell 19.1% to close at $8.12. Sorrento Therapeutics, last week, announced it has entered into a merger agreement to acquire SmartPharm and develop a pipeline of gene-encoded therapeutic antibodies, starting with neutralizing antibodies to treat Covid-19 and cancer therapeutics.
Vir Biotechnology, Inc. (NASDAQ:VIR) dropped 18.8% to close at $42.95. Vir Biotechnology and Harbour BioMed announced plans to collaborate on development and commercialization of novel therapeutic molecules in the field of immuno-oncology and infectious disease.
Lifeway Foods, Inc. (NASDAQ:LWAY) dipped 17.7% to close at $4.79.
GrowGeneration Corp. (NASDAQ:GRWG) fell 17.3% to close at $14.34. On Friday, Hindenburg published a bearish piece on GrowGeneration.
Urban One, Inc. (NASDAQ:UONE) dropped 17.3% to close at $4.15. Urban One, earlier during the month, reported a $25 million at-the-market equity offering program.
Immunic, Inc. (NASDAQ:IMUX) dipped 17.1% to close at $15.29.
Ovid Therapeutics Inc. (NASDAQ:OVID) fell 16.8% to close at $6.37. Ovid Therapeutics released Q2 results earlier in the month.
Kirkland's, Inc. (NASDAQ:KIRK) fell 16.6% to close at $10.18. Kirkland's is expected to release Q2 earnings on September 3.
Akers Biosciences, Inc. (NASDAQ:AKER) dipped 16.6% to close at $4.38 after falling 11% on Friday. Akers Biosciences, earlier during the month, announced a 1.207 million share common stock offering at $5.67 per share.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares fell 16.3% to close at $1.95.
Vuzix Corporation (NASDAQ:VUZI) fell 15.8% to close at $3.63. Vuzix shares climbed over 17% on Friday after Rozetta selected the company's Smart Glasses for two separate translation-centric solutions.
Co-Diagnostics, Inc. (NASDAQ:CODX) declined 15.4% to close at $12.57. Co-Diagnostics, earlier during the month, reported worse-than-expected Q2 results.
Marathon Patent Group, Inc. (NASDAQ:MARA) fell 14.8% to close at $2.31. Marathon Patent Group, earlier in the month, announced it has entered into a long term purchase contract with Bitmain for the purchase of 10,500 next-generation Antminer S-19 Pro ASIC Miners.
Westwater Resources, Inc. (NASDAQ:WWR) shares dipped 14.4% to close at $1.84. Westwater Resources posted a Q2 loss of $0.43 per share earlier in the month.
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) fell 14.2% to close at $0.3950. Hancock Jaffe Laboratories shares climbed 64% on Friday after the company announced two additional VenoValve patients from its first-in-man clinical study in Columbia reached the one-year milestone following VenoValve surgery and chronic venous insufficiency significantly improved in both patients.
Yield10 Bioscience Inc (NASDAQ:YTEN) shares fell 14.1% to close at $4.34 after the company announced a common stock offering of 835,000 shares at $4.25 per share.
Calyxt, Inc. (NASDAQ:CLXT) dropped 13.4% to close at $4.98 after declining 13% on Friday.
Novavax, Inc (NASDAQ:NVAX) fell 13.3% to close at $119.26 after reports suggesting Trump is considering fast-tracking AstraZeneca's coronavirus vaccine candidate, adding to competitive pressures. Meanwhile, Novavax initiated Phase 2 portion of Phase 1/2 clinical trial of coronavirus vaccine.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) dropped 13.2% to close at $12.24 following a report that AstraZeneca’s COVID-19 vaccine maybe fast-tracked for approval in the United States.
VBI Vaccines Inc. (NASDAQ:VBIV) shares fell 12.7% to close at $3.1850 after dropping over 6% on Friday. VBI Vaccines, last week, signed a manufacturing deal with Therapure Biomanufacturing for coronavirus vaccine candidates.
Jaguar Health, Inc. (NASDAQ:JAGX) fell 12.1% to close at $0.3930 after declining over 10% on Friday. Jaguar Health, last week, issued updates on investigator-initiated trials of crofelemer.
AIM ImmunoTech Inc (NYSE:AIM) fell 11.7% to close at $2.12. On Friday, CEO Equels Thomas K. filed a Form 4 with the SEC. The insider bought 10,730 shares at an average price of $2.33.
Capitala Finance Corp. (NASDAQ:CPTA) shares fell 11.5% to close at $10.99.
Atossa Therapeutics, Inc. (NASDAQ:ATOS) shares fell 10.7% to close at $3.02. Atossa Therapeutics, last week announced that it has enrolled and dosed the first cohort of healthy participants in the Phase 1 clinical study using AT-301, being administered by nasal spray.
Vaxart, Inc. (NASDAQ:VXRT) fell 10.5% to close at $7.36.
SPAR Group, Inc. (NASDAQ:SGRP) shares fell 10.4% to close at $0.9320 after jumping 20% on Friday. SPAR Group, last week, named Fay DeVriese as new Chief Financial Officer.
DarioHealth Corp. (NASDAQ:DRIO) shares tumbled 10.1% to close at $16.73.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) dropped 9.7% to close at $0.6097. EyePoint Pharmaceuticals secured a new purchase and marketing agreement with Vantage Outsourcing for DEXYCU.
Mohawk Group Holdings, Inc. (NYSE:MWK) fell 9.5% to close at $7.95 after the company reported a common stock offering of approximately 3.36 million shares at $7 per share.
Midatech Pharma plc (NASDAQ:MTP) fell 7.8% to close at $2.36 after surging 22% on Friday.
NN, Inc. (NASDAQ:NNBR) fell 7.7% to close at $5.48 after the company reported the sale of life sciences division for $825 million.
Naked Brand Group Limited (NASDAQ:NAKD) fell 7% to close at $0.2851 after declining 11% on Friday. Naked Brand Group, last week, entered into a global amendment with St.George Investments amending convertible promissory note issued by the company.
Super League Gaming, Inc. (NASDAQ:SLGG) fell 4.9% to close at $2.14. Super League, on Friday, announced an exclusive recreational esports partnership for its upcoming new game Venture Valley.

奧多納特治療公司(納斯達克：ODT)股價週一下跌45.4%，收於18.33美元，此前該公司公佈了Contessa的結果，Contessa是Tesetaxel的3期研究。
北方王朝礦業有限公司。(紐約證券交易所：NAK)在盤前交易中下跌38.2%，收於0.8960美元，此前《華爾街日報》的一篇報道稱，該公司計劃在阿拉斯加開採的金礦和銅礦因環境問題而面臨特朗普政府的障礙。
FTS國際公司(紐約證券交易所：FTSI)股價下跌36.5%，收於3.15美元。FTS International報告與其大多數有擔保的債券持有人就重組支持協議達成協議，將超過4億美元的債務轉換為股權。
和信代股份有限公司(納斯達克：赫克斯)股價下跌26.4%，收於1.90美元。
Tricida公司(納斯達克：TCDA)股價下跌23.6%，收於10.11美元，此前該公司收到了FDA對其針對維維瑞默的新藥申請的完整回覆信。
特雷維治療公司(納斯達克：TRVI)股價下跌21.8%，收於3.74美元。Trevi治療公司在本月早些時候發佈了第二季度業績。
蘑菇街。(紐約證券交易所：莫高窟)下跌20.4%，收報2.50美元，此前該公司公佈了第一季度業績。
CHF Solutions，Inc.(納斯達克：CHFS)下跌20%，收於0.3680美元，上週五下跌7%.瑞士信貸解決方案公司(CHF Solutions)上週公佈了1250萬美元的定價，每單位0.45美元。
納米病毒公司(紐約證券交易所：NNVC)下跌19.2%，收於3.92美元。
索倫託治療公司(納斯達克：SRNE)股價下跌19.1%，收於8.12美元。索倫託治療公司上週宣佈，它已經達成了一項合併協議，將收購智能製藥公司，並開發一系列基因編碼的治療性抗體，首先是用於治療新冠肺炎和癌症治療的中和抗體。
VIR生物技術公司(納斯達克：VIR)下跌18.8%，收於42.95美元。VIR生物技術公司和Harbour BioMed公司宣佈了在免疫腫瘤學和傳染病領域合作開發和商業化新型治療分子的計劃。
Lifeway食品公司(納斯達克：長途汽車)下挫17.7%，收報4.79美元。
GrowGeneration Corp.(納斯達克：GRWG)下挫17.3%，收報14.34美元。上週五，興登堡發表了一篇關於GrowGeneration的悲觀文章。
城市一號股份有限公司(納斯達克：UONE)下跌17.3%，收於4.15美元。本月早些時候，Urban One公佈了一項2,500萬美元的市值股票發行計劃。
免疫公司(納斯達克：IMUX)下跌17.1%，收於15.29美元。
奧維德治療公司。(納斯達克：奧維德)下挫16.8%，收報6.37美元。本月早些時候，Ovid治療公司發佈了第二季度業績。
柯克蘭百貨公司(納斯達克：柯克)下挫16.6%，收報10.18美元。柯克蘭預計將於9月3日發佈第二季度收益。
Akers生物科學公司(納斯達克：阿克爾)下挫16.6%，收報4.38美元，上週五下挫11%。本月早些時候，Akers Biosciences宣佈以每股5.67美元的價格發行120.7萬股普通股。
克利夫蘭生物實驗室公司(納斯達克：CBLI)股價下跌16.3%，收於1.95美元。
Vuzix公司(納斯達克：嗡嗡聲)下挫15.8%，收報3.63美元。週五，在Rozetta選擇了該公司的智能眼鏡作為兩個獨立的以翻譯為中心的解決方案後，Vuzix的股價上漲了17%以上。
聯合診斷公司(納斯達克：CODX)下跌15.4%，收於12.57美元。本月早些時候，聯合診斷公司公佈的第二季度業績遜於預期。
馬拉鬆專利集團。(納斯達克：瑪拉)下挫14.8%，收報2.31美元。本月早些時候，馬拉鬆專利集團宣佈已與Bitmain簽訂長期採購合同，購買10,500架下一代Antminer S-19 Pro ASIC礦工。
西水資源公司(納斯達克：WWR)股價下跌14.4%，收於1.84美元。本月早些時候，Westwater Resources公佈第二季度每股虧損0.43美元。
漢考克·傑菲實驗室公司(納斯達克：HJLI)下跌14.2%，收於0.3950美元。週五，Hancock Jaffe實驗室股價上漲64%，此前該公司宣佈，在哥倫比亞進行了首例人體臨牀研究後，又有兩名VenoValve患者達到了一年來的里程碑，兩名患者的慢性靜脈功能不全都得到了顯着改善。
義德10生物科學公司(納斯達克：YTEN)股價下跌14.1%，收於4.34美元，此前該公司宣佈以每股4.25美元的價格發行83.5萬股普通股。
Calyxt公司(納斯達克：CLXT)下跌13.4%，收於4.98美元，上週五下跌13%。
Novavax，Inc.(納斯達克：NVAX)下跌13.3%，收於119.26美元，此前有報道稱，特朗普正在考慮快速追蹤阿斯利康的冠狀病毒候選疫苗，增加了競爭壓力。與此同時，Novavax啟動了冠狀病毒疫苗1/2期臨牀試驗的2期部分。
Inovio製藥公司(納斯達克：伊諾)下跌13.2%，收於12.24美元，此前有報道稱，阿斯利康的新冠肺炎疫苗可能在美國快速獲得批准。
VBI疫苗公司。(納斯達克：VBIV)股價下跌12.7%，收於3.1850美元，上週五跌幅超過6%。上週，VBI疫苗公司與治療生物製造公司簽署了一項針對冠狀病毒候選疫苗的製造協議。
捷豹健康公司(納斯達克：JAGX)下跌12.1%，收於0.3930美元，上週五跌幅超過10%。捷豹健康上週發佈了調查人員發起的CroFelemer試驗的最新情況。
AIM免疫科技公司(紐約證券交易所：目標)下挫11.7%，收報2.12美元。上週五，首席執行官埃克斯·託馬斯·K向美國證券交易委員會提交了一份4號表格。這位內部人士以2.33美元的平均價格買入了10,730股票。
CapitalA金融公司(納斯達克：CPTA)股價下跌11.5%，收於10.99美元。
Atossa治療公司(納斯達克：阿託斯)股價下跌10.7%，收於3.02美元。Atossa治療公司上週宣佈，它已經招募了第一批健康參與者，並使用AT-301進行了第一階段臨牀研究，該研究通過鼻腔噴霧給藥。
Vaxart，Inc.(納斯達克：VXRT)下挫10.5%，收報7.36美元。
Spar Group，Inc.(納斯達克：SGRP)股價下跌10.4%，收於0.9320美元，上週五曾躍升20%。Spar Group上週任命Fay DeVriese為新的首席財務官。
DarioHealth Corp.(納斯達克：德利奧)股價暴跌10.1%，收於16.73美元。
EyePoint製藥公司(納斯達克：Eypt)下跌9.7%，收於0.6097美元。EyePoint製藥公司與Vantage外包公司就DEXYCU達成了一項新的採購和營銷協議。
莫霍克集團控股有限公司(紐約證券交易所：MWK)下跌9.5%，收於7.95美元，此前該公司公佈以每股7美元的價格發行約336萬股普通股。
Midatech製藥公司(納斯達克：MTP)下跌7.8%，收報2.36美元，上週五曾飆升22%。
NN，Inc.(納斯達克：丁腈橡膠)下挫7.7%，收報5.48美元，此前該公司公佈以8.25億美元出售生命科學部門。
裸牌集團有限公司(納斯達克：Nakd)下跌7%，收於0.2851美元，上週五下跌11%。上週，Naked Brand Group與St.George Investments達成了一項全球修正案，修改了該公司發行的可轉換本票。
超級聯賽遊戲公司(納斯達克：SLGG)下挫4.9%，收報2.14美元。週五，超級聯賽宣佈為其即將推出的新遊戲風險谷建立獨家娛樂體育合作伙伴關係。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

80 Biggest Movers From Yesterday

80 Biggest Movers From Yesterday

Gainers

Losers

Gainers

贏家

Losers

失敗者

風險及免責聲明

聲明